###begin article-title 0
ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 316 318 316 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Glioma present as one of the most challenging cancers to treat, however, understanding of tumor cell biology is not well understood. Extracellular adenosine triphosphate (ATP) could serve as a critical signaling molecule regulating tumor development. This study has examined pharmacological modulation of calcium (Ca2+) entry through store-operated channels (SOC) on cellular expression and production of immune-cell mobilizing chemokines in ATP-stimulated C6 glioma cells.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 126 129 <span type="species:ncbi:10116">rat</span>
Calcium spectrofluorometry was carried out to measure mobilization of intracellular Ca2+ [Ca2+]i following ATP stimulation of rat C6 glioma cells. Pretreatment with two inhibitors of SOC, SKF96365 or gadolinium, was used to examine for effects on [Ca2+]i. RT-PCR was performed to determine effects of purinergic stimulation on C6 cell expression of metabotropic P2Y receptors (P2YR) and the chemokines, monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8). ELISA was carried out to measure production of MCP-1 and IL-8 with ATP stimulation of glioma cells.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 71 73 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 203 205 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 326 328 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Application of ATP (at 100 muM) to C6 glioma induced an increase in [Ca2+]i with the response exhibiting two components of decay. In the presence of the SOC inhibitors, SKF96365 or gadolinium, or with Ca2+-free solution, ATP responses lacked a slow phase suggesting the secondary component was due to SOC-mediated influx of Ca2+. RT-PCR confirmed expression of purinergic P2Y-subtype receptors in C6 cells which would serve as a precursor to activation of SOC. In addition, ATP-stimulated C6 cells showed enhanced expression of the chemokines, MCP-1 and IL-8, with SKF96365 or gadolinium effective in reducing chemokine expression. Gadolinium treatment of ATP-stimulated C6 cells was also found to inhibit the production of MCP-1 and IL-8.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
These results suggest ATP-induced Ca2+ entry, mediated by activation of SOC in C6 glioma, as a mechanism leading to increased cellular expression and release of chemokines. Elevated levels of MCP-1 and IL-8 are predicted to enhance the mobility of tumor cells and promote recruitment of microglia into developing tumors thereby supporting tumor growth.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 773 774 773 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 843 844 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 947 948 947 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 949 950 949 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
Gliomas are a common form of human brain tumor but remain essentially incurable due to their innate characteristic of extreme invasiveness [1]. The development and progression of gliomas include reciprocal interactions between glioma cells with resident immune responding microglia and tumor-associated macrophages [2,3]. In particular, evidence suggests that tumor cells may produce mobilizing factors for microglia/macrophages and that chemokine responses of microglia could aid in establishing immunosuppressive environments facilitating tumor growth [4,5]. Among the most prominent glioma chemokine factors are monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) which could induce recruitment of microglia/macrophage to help support tumor progression [6,7]. Moreover, MCP-1 has been shown to directly induce angiogenesis [8] while both chemokines also act as autocrine factors to drive the invasive phenotypes of the gliomas [6,9].
###end p 10
###begin p 11
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
A spectrum of stimulatory signals is likely present in developing gliomas which activate microglial chemotactic responses and promote an overall immunosuppressive microenvironment. In particular, purinergic signaling pathways in glioma may be highly relevant in enhancement of chemotactic factors to recruit microglia to help sustain tumor growth [10,11]. Glioma cells both release and respond to ATP [12,13] with catabolism of ATP extremely low in glioma cells, compared to astrocytes, due to a marked reduction in expression and activity of enzymes that degrade ATP [14]. Importantly, depletion of ATP has been reported to reduce the size and invasive characteristics of tumors in an animal glioma model [15].
###end p 11
###begin p 12
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 398 399 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 604 606 604 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 923 926 923 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
Evidence suggests that mobilization of intracellular calcium ([Ca2+]i), mediated by activation of the purinergic subtype receptor, P2X7R by the ligand 2',3'-(benzoyl-4-benzoyl)-ATP (BzATP), serves as a link between ATP stimulation of glioma and cellular expression of chemokine and cytokine factors [16]. However, roles of other purinergic family members were also suggested since antagonism of P2X7R had no effect to inhibit factor expression and only partially suppressed calcium responses [16]. In particular, it was speculated that subtype P2YR could also be activated by BzATP thereby increasing [Ca2+]i by a rapid release from endoplasmic stores followed by a subsequent sustained influx of the ion through store-operated channels (SOC). These findings suggested the relevance of study using the endogenous compound ATP as an activator of C6 cells to determine effects of pharmacological modulation of SOC-mediated Ca2+ entry on cellular production of chemokines.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Materials
###end title 14
###begin p 15
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
All chemicals were purchased from Sigma (St.Louise, MO) unless otherwise stated. Two inhibitors of SOC were employed in this work; gadolinium [17,18] and SKF96365 [19].
###end p 15
###begin title 16
Cell culture
###end title 16
###begin p 17
###xml 591 593 584 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 342 347 <span type="species:ncbi:9796">horse</span>
###xml 366 372 <span type="species:ncbi:9913">bovine</span>
C6 glioma cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA). Cells from passage number 39-59 were used in this work. Cells were cultured in Kaighn's modification of Ham's F12 medium (F12K) with 2 mM l-glutamine modified by ATCC to contain 1.5 g/l sodium bicarbonate. The medium was then supplemented with 15% horse serum, 2.5% fetal bovine serum, 0.5 mug/ml fungizone (Invitrogen: GIBCO, Grand Island, NY) and 0.02 mg/ml gentamicin (Invitrogen: GIBCO). Cells were maintained in 100 mm culture dishes (SARSTEDT, Newton, NC) at 37degreesC in a humidified 5% CO2 air atmosphere.
###end p 17
###begin title 18
Calcium spectrofluorometry
###end title 18
###begin p 19
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 416 417 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 427 428 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 487 489 479 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 616 617 608 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The detailed procedure for calcium imaging was carried out as published [20]. Briefly, cultured C6 glioma cells were incubated with fura-2 acetoxymethyl ester (fura-2AM at 1 muM; Molecular Probes, Eugene, OR) and pluronic acid (at 1 muM) in normal physiological saline solution (PSS) for 20 min at room temperature (20-22degreesC). Cells were then washed with PSS solution containing (in mM): 126 NaCl, 5 KCl, 1 CaCl2, 1.2 MgCl2, 10 HEPES and 10 glucose (pH 7.4). In some experiments, Ca2+-free PSS was used; this solution had the same composition as PSS with the exception that EGTA was added (at 1 mM) with no CaCl2. Coverslips were placed in a perfusion chamber mounted on an inverted microscope (Zeiss, Jena, Germany) and fluorescence was measured through a 40x quartz objective lens. Alternating wavelengths (340/380 nm) of ultraviolet light were applied at 6-s intervals for excitation and fluorescence signals were measured at 510 nm of emission light. Signals were acquired from a digital camera (DVC-1310, DVC Co. Austin, TX) and were processed using an imaging system (Empix, Mississauga, ON, Canada) to determine ratios of the 340 and 380 nm intensities which were used as quantitative measures of fluorescence levels in this work.
###end p 19
###begin title 20
Semiquantitative RT-PCR
###end title 20
###begin p 21
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5 </sup>
###xml 653 654 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 369 398 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
C6 glioma cells (8 x 105 cells/well) were plated in serum-free media and the experiment was carried out the following day with addition of ATP (100 muM) in the absence or presence of SKF96365 (25 muM) or gadolinium (1 muM) for 4 h. Total RNA was isolated using TRIzol (Invitrogen: GIBCO) and then processed for the first strand complementary DNA (cDNA) synthesis using Moloney murine leukemia virus (M-MLV) reverse transcriptase (Invitrogen: GIBCO). The cDNA products were then amplified by PCR using a GeneAmp thermal cycler (Applied Biosystems, Foster City, CA). Specific sense and antisense primers with the expected product sizes are shown in Table 1. PCR conditions were as follows: initial denaturation at 95degreesC for 6 min followed by a 25- to 35- cycle amplification program consisting of denaturation at 95degreesC for 45 s, annealing at 55-60degreesC for 1 min and extention at 72degreesC for 1 min. A final extention was carried out at 72degreesC for 10 min. For P2YR expression study, the PCR cycle was set at 35 cycles for all subtype receptors. Amplification of the constitutively expressed enzyme D-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a reaction standard. The amplified PCR products were identified using 1.5% agarose gels containing ethidium bromide (final concentration 0.5 mug/ml) and visualized under ultraviolet light. The intensities of each band were measured by densitometry using NIH Image J 1.37b software (National Institute of Health, Bethesda, MD) and expressed as relative mRNA levels (mRNA levels normalized to GAPDH).
###end p 21
###begin p 22
Primer sequences and product sizes
###end p 22
###begin title 23
ELISA
###end title 23
###begin p 24
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5 </sup>
###xml 272 275 <span type="species:ncbi:10116">rat</span>
###xml 286 289 <span type="species:ncbi:10116">rat</span>
C6 cells were plated using serum-free media in a 24-well plate at 3 x 105 cells/well and were allowed to acclimate for 24 h before starting the experiment. ATP was applied to the cells with or without gadolinium for 48 h and culture media were collected and analyzed with rat MCP-1 and rat IL-8 (GRO/KC) ELISA kit (Peprotech, Rockey Hill, NJ) according to the manufacturer's protocol. The detection limits were 47 and 16 pg/ml for MCP-1 and IL-8, respectively.
###end p 24
###begin title 25
Statistical analysis
###end title 25
###begin p 26
###xml 88 90 86 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
Data are presented as means +/- standard error of mean (SEM). Statistical significance (p < 0.05) was evaluated using one-way analysis of variance followed by Student-Newman-Keuls multiple comparison test (GraphPad Prism 3.0; San Diego, CA).
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
ATP-induced changes in Ca2+ mobilization
###end title 28
###begin p 29
###xml 91 93 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 179 181 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 205 207 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 273 275 272 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 349 351 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 446 447 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 485 488 484 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 540 542 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 543 545 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 705 707 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 735 737 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 738 740 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 936 938 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1C</xref>
###xml 958 960 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1D</xref>
###xml 1064 1066 1061 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1082 1084 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 1136 1138 1133 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1164 1166 1161 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1290 1292 1287 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1E</xref>
###xml 1411 1413 1408 1410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Application of ATP (100 muM) to C6 glioma cells resulted in an early phase of increased [Ca2+]i which rapidly declined and was followed by a sustained component of response (Fig. 1A). In the presence of Ca2+-free PSS (0 PSS), ATP administration led to a single phase of [Ca2+]i mobilization representing only the rapid portion of the response (Fig. 1B). These results suggested ATP binding to a P2YR activating an inositol 1,4,5-trisphosphate (IP3)-mediated intracellular release of Ca2+ and a subsequent entry of divalent ion through SOC [21,22]. To test this possibility two inhibitors of SOC, gadolinium and SKF96365, were applied prior to ATP stimulation. The concentrations of gadolinium (at 1 muM) [18] and SKF96365 (at 25 muM) [23,24] were chosen according to ones used in previous studies which were found effective for SOC inhibition. Representative ATP responses are presented with pre-treatment (3 min) with gadolinium (Fig. 1C) or SKF96365 (Fig. 1D). Exposure of C6 to either SOC inhibitor yielded a pattern of ATP response close to that observed in Ca2+-free PSS (Fig. 1B) with attenuation of the prolonged component of [Ca2+]i. Peak amplitudes of [Ca2+]i responses did not appreciably differ between control or the different treatments. Overall results are summarized in Fig. 1E (N = 4/treatment) and show durations (measured at half-maximal of peak value) of ATP responses were similar between Ca2+-free PSS and treatments with the two SOC inhibitors. Respective inhibitions of response durations relative to control ATP response were 44% (0 PSS), 49% (gadolinium) and 55% (SKF96365).
###end p 29
###begin p 30
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP-induced changes in [Ca<sup>2+</sup>]i in C6 glioma</bold>
###xml 165 167 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 219 221 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3+</sup>
###xml 497 499 492 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
ATP-induced changes in [Ca2+]i in C6 glioma. (A) Representative response for ATP (100 muM) showing rapid and slow components of decay. (B) Typical ATP response in Ca2+-free PSS. (C) ATP response following gadolinium (Gd3+) pretreatment (1 muM, for 3 min). (D) ATP response in the presence of SKF96365 (25 muM, pretreatment for 3 min). (E) Quantification of durations of ATP responses for the different treatments (measured at one-half of peak response; N = 4/treatment). Values are mean +/- SEM. *p < 0.001 compared with control.
###end p 30
###begin title 31
Expression of purinergic P2YR in C6 glioma
###end title 31
###begin p 32
###xml 186 187 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 243 244 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 249 250 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 255 257 255 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4 </sub>
###xml 264 266 264 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sub>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 582 583 582 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 590 591 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 598 599 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 606 607 606 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 700 701 700 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
RT-PCR experiments were undertaken to determine the expression of P2YR in unstimulated and ATP-stimulated C6 cells. The study examined only those P2YR known to be G protein coupled to IP3-dependent intracellular stores [21,22] and included P2Y1, P2Y2, P2Y4 and P2Y6 receptors. Typical expression of these subtype receptors are presented in Fig. 2 for control and ATP stimulation of C6 glioma for 4 h. Expression of mRNA for any of the subtype P2YR were unchanged between control and cells exposed to ATP treatment. The levels of band intensities occurred in the following order: P2Y2R > P2Y1R > P2Y6R > P2Y4R. Consistent results were obtained in three additional experiments with the intensity of P2Y2R exceeding levels for the other subtype P2YR for both control and ATP-stimulated glioma. Exposure of cells to longer-term ATP solution (48 h) had no significant effect to alter expression of any of the subtype P2YR (data not shown).
###end p 32
###begin p 33
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of P2YR linked to calcium stores in rodent C6 glioma</bold>
###xml 99 100 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 111 113 111 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4 </sub>
###xml 120 122 120 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sub>
Expression of P2YR linked to calcium stores in rodent C6 glioma. The levels of receptor subtype P2Y1, P2Y2, P2Y4 and P2Y6 were examined in control and ATP-stimulated C6 cells (100 muM; 4 h exposure). The number of PCR cycles was 35 for all receptor subtypes. GAPDH served as a reaction standard. Data are representatives from 4 independent experiments.
###end p 33
###begin title 34
Expression of chemokines MCP-1 and IL-8 in ATP-stimulated C6 cells
###end title 34
###begin p 35
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 741 743 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
Chemokines, such as MCP-1 and IL-8, released from ATP-stimulated glioma could act to mobilize immune cells nearby tumor microenvironments. Representative RT-PCR for these two chemokines is presented in Fig. 3A for the different treatments (4 h exposure) applied to C6 glioma cells. Application of ATP (100 muM) markedly enhanced expression of MCP-1 and IL-8 relative to control. Treatments of SKF96365 (25 muM) or gadolinium (1 muM) with ATP attenuated chemokine expression compared with ATP alone. Application of SKF96365 or gadolinium alone showed mRNA for MCP-1 and IL-8 similar to control. Quantification for the relative expression of the two chemokines with the different treatments (N = 4/treatment) of C6 glioma is presented in Fig. 3B. ATP stimulation increased expression of MCP-1 by 4.4-fold and IL-8 by 3.2-fold relative to control. Expression of MCP-1 was significantly reduced with SKF96365 (by 78%) and gadolinium (by 64%) treatment of ATP-stimulated C6 relative to ATP application alone. The corresponding decreases for IL-8 were 46% with SKF96365 and 40% with gadolinium with both values representing significant effects of the SOC antagonists.
###end p 35
###begin p 36
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of MCP-1 and IL-8 in C6 cells</bold>
###xml 219 221 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3+</sup>
###xml 250 253 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 447 448 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 481 482 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Expression of MCP-1 and IL-8 in C6 cells. (A) Representative levels for MCP-1 (upper row) and IL-8 (middle row) for the different treatments (4 h) applied to C6 glioma. Concentrations of ATP, SKF96365 and gadolinium (Gd3+) were the same as used in Ca2+ studies (Fig. 1). GAPDH served as a reaction standard (lower row). (B) Overall results (N = 4 experiments) showing relative chemokine expression normalized with GAPDH. Values are mean +/- SEM. *p < 0.05 compared with control, **p < 0.05 compared with ATP-treated group.
###end p 36
###begin title 37
Production of MCP-1 and IL-8 in ATP-stimulated C6 cells
###end title 37
###begin p 38
###xml 722 724 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 899 901 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
We next examined if the enhancing effect of ATP and the inhibitory effect of SOC inhibitors on chemokine expression were translated at the protein levels. Preliminary ELISA studies showed that production of both MCP-1 and IL-8 was detectable as early as 4 h but in the low range of detection limits for up to 24 h after ATP stimulation. Subsequent experiments used a 48 h exposure of C6 glioma to ATP with gadolinium studied as an SOC inhibitor. Sustained exposure of C6 cells to SKF96365 (25 muM) caused cytotoxicity to cells thus precluding use of this compound for longer-term treatment. The overall results (N = 4/treatment) show MCP-1 production was increased by 131% with ATP stimulation compared with control (Fig. 4A). Inclusion of gadolinium with ATP significantly attenuated MCP-1 (by 64%) relative to ATP alone. Levels of IL-8 were also enhanced by ATP (by 92%) compared to control (Fig. 4B). Addition of gadolinium with ATP was effective in reducing levels of IL-8 by 54% compared to ATP applied alone.
###end p 38
###begin p 39
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Production of MCP-1 and IL-8 in C6 glioma</bold>
###xml 130 132 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3+</sup>
###xml 378 380 374 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 453 455 449 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
Production of MCP-1 and IL-8 in C6 glioma. C6 cells were treated with ATP (100 muM) in the presence, or absence, of gadolinium (Gd3+, 1 muM) for 48 h. (A) Levels of MCP-1 production (ng/ml) and (B) levels of IL-8 production (pg/ml) for the different treatments. Data are presented as mean +/- SEM from 4 independent experiments. * indicates significant difference from control (p < 0.001) and ** indicates significant difference from ATP-treated group (p < 0.05).
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 805 806 805 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
The results from this work demonstrate that ATP stimulation of C6 glioma causes an increased cellular expression and production of the chemokines, MCP-1 and IL-8. These chemokines could serve as potent factors to mobilize tumor cells and also recruit microglia to help promote tumor development. Both expression and release of chemokines were inhibited by antagonists for SOC-mediated influx of Ca2+ suggesting ATP induced the activation of a SOC-dependent pathway. Our findings lead to the novel suggestion that ATP binding to a metabotropic P2YR, coupled to activation of SOC, as an underlying mechanism for chemokine production in tumor cells. As discussed below, these findings are distinct from previous work reporting increased levels of these chemokines mediated by activation of the ionotropic P2X7R with the ligand, BzATP [16].
###end p 41
###begin p 42
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 220 222 220 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 411 414 411 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 513 516 513 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 670 673 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 728 731 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 781 782 781 782 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Calcium-sensitive spectrofluorometry showed ATP-induced increases in [Ca2+]i consisted of two components of response decay with the rapid and slow phases representing respective store release and plasmalemmal entry of Ca2+. In the presence of inhibitors of SOC, SKF96365 or gadolinium, the secondary but not initial, component of response was suppressed. Both SOC inhibitors were highly effective in blocking Ca2+ entry since durations of ATP responses with either compound were similar to those measured using Ca2+ free solution. It should be noted that no specific SOC antagonist has yet been identified with both SKF96365 and gadolinium capable of modulating other Ca2+ entry pathways. The findings and implication for two Ca2+ influx channels in glioma, SOC (this work) and P2X7R [16], are considered in more detail below.
###end p 42
###begin p 43
###xml 80 81 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 94 95 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 104 105 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 234 235 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 612 613 612 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 765 767 765 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 886 887 886 887 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 896 897 896 897 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 930 931 930 931 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 940 941 940 941 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
RT-PCR was used to determine expression of metabotropic purinergic receptors P2Y1R, P2Y2R, P2Y4R and P2Y6R which are linked to IP3-mediated mobilization of [Ca2+]i [21]. Unstimulated C6 glioma showed a prominent band intensity for P2Y2R with a relatively lower basal expression for the other P2YR. The expression for any of the subtype P2YR was not altered with exposure of C6 cells to ATP (4 h treatment). Interestingly, longer-term exposure (48 h) of C6 glioma to ATP had no appreciable effect to alter mRNA expression for any of the P2YR (data not shown). Although our results show prominent expression of P2Y2R in glioma, future studies on protein levels and use of specific purinergic agonists and antagonists will have utility in linking specific P2YR with Ca2+-dependent responses. It is noteworthy that P2Y subtype receptors exhibit differential activation with purines with P2Y1R and P2Y6R more sensitive to ADP while P2Y2R and P2Y4R are more sensitive to ATP [21].
###end p 43
###begin p 44
###xml 765 766 765 766 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 848 850 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 851 853 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
ATP stimulation of C6 glioma (4 h exposure) enhanced expression of the potent microglial-mobilizing chemokines, MCP-1 and IL-8. Expression of both chemokines were significantly reduced with SKF96365 or gadolinium included with the ATP stimulation. ELISA assay demonstrated that production of both chemokines was relatively low for ATP stimulation of C6 cells for durations less than 24 h but was enhanced with longer-term (48 h) exposure. In the latter case, levels of MCP-1 and IL-8 were significantly diminished with gadolinium included in the ATP treatment. It is noteworthy that the stimulatory effects of ATP on MCP-1 and IL-8 production were markedly lower compared to other agents releasing chemokines from astrocytic cell types. These agents include the P2X7R agonist, BzATP [25] and the pro-inflammatory cytokines TNF-alpha, and IL-1beta [26,27].
###end p 44
###begin p 45
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 255 256 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 624 625 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 899 902 899 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
The increased chemokine expression and production was not directly attributable to changes in receptor expression since none of the P2YR showed changes in band intensity with ATP treatment (Fig. 2). It is possible that the high basal levels of subtype P2Y2R expression in control would preclude RT-PCR analysis showing any increases in this subtype receptor after exposure of C6 cells to ATP. Gadolinium treatment was demonstrated to significantly reduce levels of MCP-1 and IL-8 in ATP-stimulated C6 cells. However, the inclusion of gadolinium with ATP did not diminish chemokine productions to control levels. Although P2X7R could contribute, this possibility is unlikely since ATP levels near 1 mM are generally required for activation of this receptor [28,29]. Our results do not exclude involvement of other P2XR since it is known that subtype receptors from the P2X family mediate influx of Ca2+ into stimulated cells [12].
###end p 45
###begin p 46
###xml 29 31 29 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 277 278 277 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 571 574 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
###xml 660 662 660 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 918 919 918 919 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
Together with previous data [16], C6 glioma cells are shown to express at least two different purinergic-dependent Ca2+ entry pathways which modulate cellular releases of the chemokines, MCP-1 and IL-8. Activation of SOC subsequent to ATP binding to a P2YR or activation of P2X7R [16] with BzATP (ATP was not studied as an agonist) is coupled to C6 chemokine production. The overall results suggest that in C6 glioma, two different calcium influx pathways converge with the same functional endpoint of enhanced chemokine release. The effects of SOC inhibitors on rapid Ca2+ responses and on longer-term cell functional responses indicates the involvement of Ca2+-dependent transcription factors in mediating tumor cell production of chemokines. One possibility is that release of chemokines such as MCP-1 and IL-8 from C6 are modulated by SOC activation with physiological ATP concentrations whereas the purinergic P2X7R pathway only contributes under extremely elevated levels of ATP.
###end p 46
###begin p 47
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
Our findings suggest that pharmacological antagonism of SOC could serve as a rationale strategy to inhibit tumor growth. The SOC-dependent secretion of MCP-1 and IL-8 from C6 glioma would increase tumor cell mobility and also act as mobilization and proliferation signals to direct resident microglia into expanding tumors. It has been pointed out that recruitment of microglia could aid in supporting an immunosuppressive tumor environment to counter effects of T-cell-mediated killing of tumor cells [4]. However, recent findings also indicate that under certain conditions activated microglia/macrophages are capable of killing glioma cells [30,31]. Thus, it seems likely that microglia/macrophages could play both pro- or anti-neoplastic roles depending on the signaling factors present in the tumor microenvironment.
###end p 47
###begin title 48
Conclusions
###end title 48
###begin p 49
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+ </sup>
Our results suggest ATP-induced Ca2+ entry, mediated by activation of SOC in C6 glioma, as a mechanism linked to the cellular expression and release of chemokines. Increased levels of MCP-1 and IL-8 are predicted to enhance the mobility of tumor cells and promote recruitment of microglia into developing tumors thereby supporting tumor growth. Pharmacological inhibition of SOC in astroglioma is suggested as a novel treatment strategy to inhibit tumor progression.
###end p 49
###begin title 50
Competing interests
###end title 50
###begin p 51
The authors declare that they have no competing interests.
###end p 51
###begin title 52
Authors' contributions
###end title 52
###begin p 53
NJ designed research, performed research, analyzed data, and wrote the manuscript. HBC analyzed data JGM designed research, analyzed data, and wrote the manuscript. All authors have read and approved the final manuscript.
###end p 53
###begin title 54
Pre-publication history
###end title 54
###begin p 55
The pre-publication history for this paper can be accessed here:
###end p 55
###begin p 56

###end p 56
###begin title 57
Acknowledgements
###end title 57
###begin p 58
Funding from Canadian Institute for Health Research supported this work (to JGM).
###end p 58
###begin article-title 59
Molecular pathology of malignant gliomas
###end article-title 59
###begin article-title 60
Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment
###end article-title 60
###begin article-title 61
Role of microglia in glioma biology
###end article-title 61
###begin article-title 62
Microglia function in brain tumors
###end article-title 62
###begin article-title 63
Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion
###end article-title 63
###begin article-title 64
Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas
###end article-title 64
###begin article-title 65
'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis
###end article-title 65
###begin article-title 66
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor
###end article-title 66
###begin article-title 67
###xml 65 70 <span type="species:ncbi:9606">human</span>
Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness
###end article-title 67
###begin article-title 68
Purinergic signalling in neuron-glia interactions
###end article-title 68
###begin article-title 69
P2 receptors and cancer
###end article-title 69
###begin article-title 70
Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides
###end article-title 70
###begin article-title 71
Release of ATP and UTP from astrocytoma cells
###end article-title 71
###begin article-title 72
Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines
###end article-title 72
###begin article-title 73
###xml 64 67 <span type="species:ncbi:10116">rat</span>
In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model
###end article-title 73
###begin article-title 74
###xml 50 53 <span type="species:ncbi:10116">rat</span>
Expression and function of the P2X(7) receptor in rat C6 glioma cells
###end article-title 74
###begin article-title 75
###xml 94 97 <span type="species:ncbi:10116">rat</span>
A non-capacitative pathway activated by arachidonic acid is the major Ca2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin
###end article-title 75
###begin article-title 76
Calmidazolium and arachidonate activate a calcium entry pathway that is distinct from store-operated calcium influx in HeLa cells
###end article-title 76
###begin article-title 77
###xml 99 104 <span type="species:ncbi:9606">human</span>
Differential activation of subtype purinergic receptors modulates Ca(2+) mobilization and COX-2 in human microglia
###end article-title 77
###begin article-title 78
###xml 92 100 <span type="species:ncbi:9606">patients</span>
Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients
###end article-title 78
###begin article-title 79
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes
###end article-title 79
###begin article-title 80
Cross-talk between the ATP and ADP nucleotide receptor signalling pathways in glioma C6 cells
###end article-title 80
###begin article-title 81
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
Receptor-activated Ca2+ influx via human Trp3 stably expressed in human embryonic kidney (HEK)293 cells. Evidence for a non-capacitative Ca2+ entry
###end article-title 81
###begin article-title 82
Novel activation of non-selective cationic channels by dinitrosyl iron-thiosulfate in PC12 cells
###end article-title 82
###begin article-title 83
P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase
###end article-title 83
###begin article-title 84
Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR
###end article-title 84
###begin article-title 85
###xml 89 94 <span type="species:ncbi:9606">human</span>
Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: implications for inflammatory gene expression
###end article-title 85
###begin article-title 86
Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP
###end article-title 86
###begin article-title 87
Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors
###end article-title 87
###begin article-title 88
TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia
###end article-title 88
###begin article-title 89
###xml 76 80 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice
###end article-title 89

